Infectivity of blood products from donors with occult hepatitis B virus infection

Transfusion

Volumn 53, Issue 7, 2013, Pages 1405-1415

  Allain, Jean Pierre ^a   Mihaljevic, Ivanka ^a   Gonzalez Fraile, Maria Isabel ^a   Gubbe, Knut ^a   Holm Harritshøj, Lene ^a   Garcia, Jose Maria ^a   Brojer, Ewa ^a   Erikstrup, Christian ^a   Saniewski, Mona ^a   Wernish, Lorenz ^a   Bianco, Lydia ^a   Ullum, Henrik ^a   Candotti, Daniel ^a   Lelie, Nico ^a   Gerlich, Wolfram H ^a   Chudy, Michael ^a  

^a UNIVERSITY OF CAMBRIDGE   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

FRESH FROZEN PLASMA; HEPATITIS B CORE ANTIBODY; HEPATITIS B SURFACE ANTIBODY; THROMBOCYTE CONCENTRATE; VIRUS DNA;

ADULT; AGED; ARTICLE; BLOOD; BLOOD DONOR; BLOOD TRANSFUSION REACTION; BLOODSTREAM INFECTION; CLINICAL ARTICLE; ERYTHROCYTE; FEMALE; GENOMICS; HEPATITIS B; HEPATITIS B VIRUS; HUMAN; INFECTION RISK; MALE; PLASMA VOLUME; PROCEDURES; SEQUENCE HOMOLOGY; SEROLOGY; VIRUS LOAD; VIRUS TRANSMISSION;

ADULT; AGED; BLOOD DONORS; BLOOD TRANSFUSION; FEMALE; HEPATITIS B; HEPATITIS B ANTIBODIES; HEPATITIS B VIRUS; HUMANS; MALE; MIDDLE AGED; MUTATION; RISK FACTORS;

EID: 84880242413     PISSN: 00411132     EISSN: 15372995     Source Type: Journal    
DOI: 10.1111/trf.12096     Document Type: Article

References (34)

1. Allain JP, Cox L,. Challenges in hepatitis B detection among blood donors. Curr Opin Hematol 2011; 18: 461-466.
2. Candotti D, Grabarczyk P, Ghiazza P, Roig R, Casamitjana N, Iudicone P, Schmidt M, Bird A, Crookes R, Brojer E, Miceli M, Amiri A, Li C, Allain JP,. Characterization of occult hepatitis B virus from blood donors carrying genotype A2 or genotype D strains. J Hepatol 2008; 49: 537-547.
3. Allain JP, Belkhiri D, Vermeulen M, Crookes R, Cable R, Amiri A, Reddy R, Bird A, Candotti D,. Characterization of occult hepatitis B virus strains in South African blood donors. Hepatology 2009; 90: 1868-1876.
4. Candotti D, Lin CK, Belkhiri D, Sakuldamrongpanich T, Biswas S, Lin S, Teo D, Ayob Y, Allain JP,. Occult hepatitis B infection in asymptomatic blood donors from South East Asia: molecular characterization and potential mechanisms of occurrence. Gut 2012; 61: 1744-1753.
5. Satake M, Taira R, Yugi H, Hino S, Kanemitsu K, Ikeda H, Tadokoro K,. Infectivity of blood components with low hepatitis B virus DNA levels identified in a look back program. Transfusion 2007; 47: 1197-1205.
6. Gerlich WH, Wagner FF, Chudy M, Holm-Harritshoj L, Lattermann A, Wienzek S, Glebe D, Saniewski M, Schüttler CG, Wend UC, Willems WR, Bauerfeind U, Jork C, Bein G, Platz P, Ullum H, Dickmeiss E,. HBsAg non-reactive HBV infection in blood donors: transmission and pathogenicity. J Med Virol 2007; 79: S32-36.
7. Levicnik-Stezinar S, Rahne-Potokar U, Candotti D, Lelie N, Allain JP,. HBs positive occult hepatitis B virus carrier blood infectious in two transfusion recipients. J Hepatol 2008; 48: 1022-1025.
8. Wang JT, Lee CZ, Chen PJ, Wang TH, Chen DS,. Transfusion-transmitted HBV infection in an endemic area: the necessity of more sensitive screening for HBV carriers. Transfusion 2002; 42: 1592-1597.
9. Yuen MF, Wong DK, Lee CK, Tanaka Y, Allain JP, Fung J, Leung J, Lin CK, Sugiyama M, Sugauchi F, Mizokami M, Lai CL,. Transmissibility of hepatitis B infection through blood transfusion from blood donors with occult hepatitis B virus infection. Clin Infect Dis 2011; 52: 624-632.
10. Su TH, Chen PJ, Chen TC, Cheng HR, Li L, Lin KS, Kao JH,. The clinical significance of occult hepatitis B transfusion in Taiwan: a look back study. Transfus Med 2011; 21: 33-41.
11. Brojer E, Grabarczyk P, Liszewski G, Mikulska M, Allain JP, Letowska M,. Characterization of HBV DNA positive/HBsAg negative blood donors identified in the Polish NAT screening program. Hepatology 2006; 44: 1666-1674.
12. Gerlich WH,. Breakthrough of hepatitis B virus escape mutants after vaccination and virus reactivation. J Clin Virol 2006; 36 (Suppl 1): S18-22.
13. Zahn A, Li C, Danso K, Candotti D, Owusu-Ofori S, Temple J, Allain JP,. Molecular characterization of occult hepatitis B virus in genotype E-infected subjects. J Gen Virol 2008; 89: 409-418.
14. Bremer CM, Saniewski M, Wend UC, Torres P, Lelie N, Gerlich WH,. Transient occult hepatitis B virus infection in a blood donor with high viremia. Transfusion 2009; 49: 1621-1629.
15. Finney DJ,. Probit analysis. 3rd ed. Cambridge, UK: Cambridge University Press; 1971.
16. Velati C, Romanò L, Fomiatti L, Baruffi L, Zanetti AR,; SIMTI Research Group. Impact of nucleic acid testing for hepatitis B virus, hepatitis C virus, and human immunodeficiency virus on the safety of blood supply in Italy: a 6 year survey. Transfusion 2008; 48: 2205-2213.
17. Lieshout-Krikke RW, van't Ende EA, Slot E, Karomi S, Kivit RM, Zaaijer HL,. Infectivity of pre-seroconversion donations: an analysis of lookback exercises in the Netherlands, 2000-2006. Vox Sang 2012; 102: 193-197.
18. Kleinman S, Marshall D, AuBuchon J, Patton M,. Survival after transfusion as assessed in a large multistate US cohort. Transfusion 2004; 44: 386-390.
19. Braito A, Bianchini AM, Mattei C, Benci A, Marri D, Toti M,. Decline of HBsAg antibodies after immunization with hepatitis B vaccines and after natural infection. Boll Ist Sieroter Milan 1991-1992; 70: 449-451.
20. Scheutz F, Melbye M, Esteban JI, Aldershvile J, Ebbesen P, Alter HJ,. Hepatitis B virus infection in Danish dentists. A case-control and follow-up study. Am J Epidemiol 1988; 128: 190-196.
21. Lõpez-Izquierdo R, Udaondo MA, Zarzosa P, García-Ramõn E, Garcinuño S, Bratos MA, Orduña A, Rodríguez-Torres A, Almaraz A,. Seroprevalence of viral hepatitis in a representative general population of an urban public health area in Castilla y Leon (Spain). Enferm Infecc Microbiol Clin 2007; 25: 317-323.
22. Thierfelder W, Hellenbrand W, Meisel H, Schreier E, Dortschy R,. Prevalence of markers for hepatitis A, B and C in the German population. Results of the German National Health Interview and Examination Survey 1998. Eur J Epidemiol 2001; 17: 429-435.
23. Hui CK, Cheung WW, Zhang HY, Au WY, Yueng YH, Leung GK, Leung N, Luk JM, Lie AK, Kwong YL, Liang R, Lau GK,. Kinetics and risk of de novo hepatitis B infection in HBsAg-negative patients undergoing cytotoxic chemotherapy. Gastroenterology 2006; 131: 59-68.
24. Westhoff TH, Jochimsen F, Schmittel A, Stoffler-Meilicke M, Schafer JH, Zidek W, Gerlich WH, Thiel E,. Fatal hepatitis B virus reactivation by an escape mutant following rituximab therapy. Blood 2003; 102: 1930.
25. Power JP, El Chaar M, Temple J, Thomas M, Spillane D, Candotti D, Allain JP,. HBV reactivation after fludarabine chemotherapy identified on investigation of suspected transfusion-transmitted hepatitis B virus. J Hepatol 2010; 53: 780-787.
26. Raimondo G, Allain JP, Brunetto MR, Buendia MA, Chen DS, Colombo M, Craxì A, Donato F, Ferrari C, Gaeta GB, Gerlich WH, Levrero M, Locarnini S, Michalak T, Mondelli MU, Pawlotsky JM, Pollicino T, Prati D, Puoti M, Samuel D, Shouval D, Smedile A, Squadrito G, Trépo C, Zoulim F, et al. Statements from the Taormina expert meeting on occult hepatitis B virus infection. J Hepatol 2008; 49: 652-657.
27. Raimondo G, Navarra G, Mondello S, Costantino L, Colloredo G, Cucinotta E, Di Vita G, Scisca C, Squadrito G, Pollicino T,. Occult hepatitis B virus in liver tissue of individuals without hepatic disease. J Hepatol 2008; 48: 743-746.
28. El Chaar M, Candotti D, Crowthers RA, Allain JP,. Impact of hepatitis B virus surface protein mutations on the diagnosis of occult hepatitis B virus infection. Hepatology 2010; 52: 1600-1610.
29. Madalinski K, Burczynska B, Heermann KH, Uy A, Gerlich WH,. Analysis of viral proteins in circulating immune complexes from chronic carriers of hepatitis B virus. Clin Exp Immunol 1991; 84: 493-500.
30. Chudy M, Schmidt M, Czudai V, Scheiblauer H, Nick S, Mosebach M, Hourfar MK, Seifried E, Roth WK, Grünelt E, Nübling CM,. Hepatitis B virus genotype G monoinfection and its transmission by blood components. Hepatology 2006; 44: 99-107.
31. Prince AM, Lee DH, Brotman B,. Infectivity of blood from PCR-positive, HBsAg-negative, anti-HBs-positive cases of resolved hepatitis B infection. Transfusion 2001; 41: 329-332.
32. Mosley JW, Stevens CE, Aach RD, Hollinger FB, Mimms LT, Solomon LR, Barbosa LH, Nemo GJ,. Donor screening for antibody to hepatitis B core antigen and hepatitis B virus infection in transfusion recipients. Transfusion 1995; 35: 5-12.
33. Stramer S, Wend U, Candotti D, Forster G, Hollinger B, Dodd R, Allain JP, Gerlich W,. Occurrence and characterization of naturally acquired hepatitis B infection among vaccinated blood donors. N Engl J Med 2011; 364: 236-247.
34. Bouike Y, Imoto S, Mabuchi O, Kokubunji A, Kai S, Okada M, Taniguchi R, Momose S, Uchida S, Nishio H,. Infectivity of HBV DNA positive donations identified in look-back studies in Hyogo prefecture, Japan. Transfus Med 2011; 21: 107-115.